KaloCyte, Inc.

670 West Baltimore Street, HSRF III, 8th Floor
Baltimore MD 21201
About Us

KaloCyte was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care and is poised to deliver ErythroMer, a dried, bio-inspired artificial red blood cell, to market. ErythroMer is envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. KaloCyte is supported by nearly $6M in federal awards and investor funding.

Powered By GrowthZone